Terns Pharmaceuticals (TERN) Operating Leases (2022 - 2023)
Terns Pharmaceuticals (TERN) has disclosed Operating Leases for 2 consecutive years, with $63000.0 as the latest value for Q3 2023.
- For the quarter ending Q3 2023, Operating Leases fell 91.03% year-over-year to $63000.0, compared with a TTM value of $63000.0 through Sep 2023, down 91.03%, and an annual FY2022 reading of $544000.0, changed N/A over the prior year.
- Operating Leases was $63000.0 for Q3 2023 at Terns Pharmaceuticals, down from $223000.0 in the prior quarter.
- Across five years, Operating Leases topped out at $1.0 million in Q1 2022 and bottomed at $63000.0 in Q3 2023.